KEY FINDINGS
The global anti-depressant drugs, devices and therapies market is anticipated to grow at a CAGR of 1.81% CAGR during the year 2019-2027. The revenue generated by the market is expected to increase from $15,569 million in 2018 and reach $18,183 million by 2027. The antidepressant drugs, devices, and therapies market is primarily driven because of factors such as a shift in the geriatric population size, growing awareness about depression as a medical disorder and the surge in sales of antidepressants in the past few years.
MARKET INSIGHTS
The market is segmented into types of antidepressants drugs, types of devices and the types of therapies for further simplification and a thorough study of the services and trends followed by the market players. The high cost for depression therapies, patent expiration faced by the companies for several drugs, coupled with the delay in product launches are majorly restraining the progression and expansion of the market. However, with the rising awareness about depression being a medical condition, the market is expected to show a huge promise during the forecasted years. Moreover, the rapid ongoing research and development activities for the drug discovery in the global depressant market are expected to find new, cost-effective and impactful antidepressant drug.
REGIONAL INSIGHTS
Geographically, the global anti-depressant drugs, devices, and therapies market is bifurcated into North America, Europe, Asia Pacific, and the remaining countries constituting the Rest of World segment.
The North American market is expected to hold the biggest share by 2027 on account of its developed healthcare system and increased expenditure on mental health treatment. However, this market is facing a possibility of dilution on account of the patent expiry of most of the prescribed drugs. On the contrary, the Asia-Pacific market is expected to be the fastest-growing region for the anti-depressant drugs, devices, and therapies market. The level of awareness regarding depression is steadily increasing in countries such as India, China, Japan, and South Korea, as deducted from the significant market share determined by our study, which determines this region as a prospective market in the upcoming years.
COMPETITIVE INSIGHTS
Branded drug manufacturing companies generally invest in R&D and produce drugs in-house. Some of the major blockbuster drugs produced by branded drug companies are H. Lundbeck AS, Boehringer Ingelheim GmbH, Allergan PLC, Mayo Clinic, Brainsway, Pfizer, Neuronetics, Abbot Laboratories, F. Hoffmann-La Roche Ltd., Eli Lilly, and Company and GlaxoSmithKline. They have reaped billions of dollars by having market exclusivity and patents.
Global Antidepressants Drugs, Devices And Therapies Market Forecast 2019-2027
Table of Contents
1. Research Scope
1.1. Study Goals
1.2. Scope Of The Market Study
1.3. Who Will Find This Report Useful?
1.4. Study And Forecasting Years
2. Research Methodology
2.1. Sources Of Data
2.1.1. Secondary Data
2.1.2. Primary Data
2.2. Top-Down Approach
2.3. Bottom-Up Approach
2.4. Data Triangulation
3. Executive Summary
3.1. Market Summary
3.2. Key Findings
3.2.1. Serotonin And Norepinephrine Reuptake Inhibitors (Snris) Is The Dominant Drug In Antidepressants Market
3.2.2. Deep Brain Stimulator Is Expected To Grow Fast Among Other Devices Over The Forecast Period
3.2.3. Cognitive Behavior Therapy (Cbt) Is The Largest Contributor To Antidepressants Therapies Market
4. Market Dynamics
4.1. Market Definition & Scope
4.2. Market Drivers
4.2.1. Rise In The Number Of Depression Patients
4.2.2. Increase In Ageing Population
4.2.3. Rising Consciousness Of Depression As A Medical Disorder
4.2.4. Surge In Sales Of Antidepressants
4.3. Market Restraints
4.3.1. High Cost Of Depression Therapy
4.3.2. Patent Expiration Faced By The Companies
4.3.3. Delay In Product Launches
4.4. Market Opportunities
4.4.1. Huge Market Potential
4.4.2. More Preference For Personnel Therapy & Device Treatment
4.5. Market Challenges
4.5.1. Stiff Competition From The Generic Drugmakers
5. Market By Antidepressants Drugs
5.1. Serotonin And Norepinephrine Reuptake Inhibitors (Snris)
5.2. Tricyclic Antidepressants (Tca)
5.3. Monoamine Oxidase Inhibitors (Maois)
5.4. Atypical Antidepressants
5.5. Selective Serotonin Reuptake Inhibitors
5.6. Benzodiazepines
5.7. Anticonvulsants
5.8. Beta-Blockers
5.9. Other Antidepressants Drugs
6. Market By Devices
6.1. Deep Brain Stimulators
6.2. Fisher Wallace Stimulators
6.3. Transcranial Magnetic Stimulator
6.4. Other Devices
7. Market By Therapies
7.1. Cognitive Behavior Therapy (Cbt)
7.2. Electroconvulsive Therapy (Ect)
7.3. Rational Emotive Behavior Therapy (Rebt)
7.4. Other Therapies
8. Key Analytics
8.1. Porter's Five Force Model
8.1.1. Threat Of New Entrants
8.1.2. Threat Of Substitute
8.1.3. Bargaining Power Of Suppliers
8.1.4. Bargaining Power Of Buyers
8.1.5. Threat Of Competitive Rivalry
8.2. Opportunity Matrix
8.3. Vendor Landscape
8.4. Value Chain Analysis
8.4.1. For Drugs
8.4.2. For Devices
8.5. Key Buying Criteria
9. Geographical Analysis
9.1. North America
9.1.1. United States
9.1.2. Canada
9.2. Europe
9.2.1. Germany
9.2.2. United Kingdom
9.2.3. France
9.2.4. Spain
9.2.5. Italy
9.2.6. Russia
9.2.7. Roe (Rest Of Europe)
9.3. Asia Pacific
9.3.1. India
9.3.2. China
9.3.3. Japan
9.3.4. South Korea
9.3.5. Australia
9.3.6. Rest Of Asia Pacific (Roapac)
9.4. Rest Of World
9.4.1. Latin America
9.4.2. Middle East And Africa
10. Competitive Landscape
10.1. Market Share Analysis
10.2. Company Profile
10.2.1. Abbot Laboratories
10.2.2. Allergan Plc
10.2.3. Boehringer Ingelheim Gmbh
10.2.4. Brainsway
10.2.5. Eli Lilly And Company
10.2.6. F. Hoffmann-La Roche Ltd.
10.2.7. Glaxosmithkline
10.2.8. H. Lundbeck As
10.2.9. Mayo Clinic
10.2.10. Neuronetics
10.2.11. Pfizer
List of Tables
Table 1 Global Antidepressants Drugs, Devices And Therapies Market, By Geography, 2019-2027, (In $ Million)
Table 2 Landscape Of Drug Expiry And Launches In The United States
Table 3 Global Antidepressants Drugs, Devices And Therapies Market, By Antidepressants Drugs, 2019-2027, (In $ Million)
Table 4 Global Antidepressants Drugs Market, By Geography, 2019-2027, (In $ Million)
Table 5 Global Serotonin And Norepinephrine Reuptake Inhibitors (Snris) Market, By Region, 2019-2027, (In $ Million)
Table 6 Global Tricyclic Antidepressants (Tca) Market, By Region, 2019-2027, (In $ Million)
Table 7 Global Monoamine Oxidase Inhibitors (Maois) Market, By Region, 2019-2027, (In $ Million)
Table 8 Global Atypical Antidepressants Market, By Region, 2019-2027, (In $ Million)
Table 9 Global Selective Serotonin Reuptake Inhibitors Market, By Region, 2019-2027, (In $ Million)
Table 10 Global Benzodiazepines Market, By Region, 2019-2027, (In $ Million)
Table 11 Global Anticonvulsants Market, By Region, 2019-2027, (In $ Million)
Table 12 Global Beta-Blockers Market, By Region, 2019-2027, (In $ Million)
Table 13 Global Other Antidepressants Drugs Market, By Region, 2019-2027, (In $ Million)
Table 14 Global Antidepressants Drugs, Devices And Therapies Market, By Devices, 2019-2027, (In $ Million)
Table 15 Global Devices Market, By Geography, 2019-2027, (In $ Million)
Table 16 Global Deep Brain Stimulators Market, By Region, 2019-2027, (In $ Million)
Table 17 Global Fisher Wallace Stimulators Market, By Region, 2019-2027, (In $ Million)
Table 18 Global Transcranial Magnetic Stimulator Market, By Region, 2019-2027, (In $ Million)
Table 19 Global Other Devices Market, By Region, 2019-2027, (In $ Million)
Table 20 Global Antidepressants Drugs, Devices And Therapies Market, By Therapies, 2019-2027, (In $ Million)
Table 21 Global Therapies Market, By Geography, 2019-2027, (In $ Million)
Table 22 Global Cognitive Behavior Therapy (Cbt) Market, By Region, 2019-2027, (In $ Million)
Table 23 Global Electroconvulsive Therapy (Ect) Market, By Region, 2019-2027, (In $ Million)
Table 24 Global Rational Emotive Behavior Therapy (Rebt) Market, By Region, 2019-2027, (In $ Million)
Table 25 Global Other Therapies Market, By Region, 2019-2027, (In $ Million)
Table 26 Opportunity Matrix
Table 27 Vendor Landscape
Table 28 Global Antidepressants Drugs, Devices And Therapies Market, By Geography, 2019-2027, (In $ Million)
Table 29 North America Antidepressants Drugs, Devices And Therapies Market, By Country, 2019-2027 (In $ Million)
Table 30 Europe Antidepressants Drugs, Devices And Therapies Market, By Country, 2019-2027 (In $ Million)
Table 31 Asia Pacific Antidepressants Drugs, Devices And Therapies Market, By Country, 2019-2027 (In $ Million)
Table 32 Rest Of World Antidepressants Drugs, Devices And Therapies Market, By Regions, 2019-2027 (In $ Million)
List of Figures
Figure 1 Global Antidepressants Drugs, Devices And Therapies Market Share, By Drugs 2018 & 2027 (%)
Figure 2 Snris Market, 2019 - 2027 (In $ Million)
Figure 3 Deep Brain Stimulators Market, 2019 - 2027 (In $ Million)
Figure 4 Cognitive Behavior Therapy (Cbt) Market ($ Million)
Figure 5 Global Antidepressants Drugs, Devices And Therapies Market, By Cognitive Behavior Therapy (Cbt), 2019-2027, (In $ Million)
Figure 6 Global Antidepressants Drugs, Devices And Therapies Market, By Electroconvulsive Therapy (Ect), 2019-2027, (In $ Million)
Figure 7 Global Antidepressants Drugs, Devices And Therapies Market, By Rational Emotive Behavior Therapy (Rebt), 2019-2027, (In $ Million)
Figure 8 Global Antidepressants Drugs, Devices And Therapies Market, Other Therapies, 2019-2027, (In $ Million)
Figure 9 Porter's Five Force Model
Figure 10 Value Chain Of Antidepressant Drugs
Figure 11 Value Chain Analysis For Device Market
Figure 12 Global Antidepressants Drugs, Devices And Therapies Market, Regional Outlook, 2018 & 2027, (%)
Figure 13 United States Antidepressants Drugs, Devices And Therapies Market, 2019-2027 (In $ Million)
Figure 14 Canada Antidepressants Drugs, Devices And Therapies Market, 2019-2027 (In $ Million
Figure 15 Germany Antidepressants Drugs, Devices And Therapies Market, 2019-2027 (In $ Million)
Figure 16 United Kingdom Antidepressants Drugs, Devices And Therapies Market, 2019-2027 (In $ Million)
Figure 17 France Antidepressants Drugs, Devices And Therapies Market, 2019-2027 (In $ Million)
Figure 18 Spain Antidepressants Drugs, Devices And Therapies Market, 2019-2027 (In $ Million)
Figure 19 Italy Antidepressants Drugs, Devices And Therapies Market, 2019-2027 (In $ Million)
Figure 20 Russia Antidepressants Drugs, Devices And Therapies Market, 2019-2027 (In $ Million)
Figure 21 Roe Antidepressants Drugs, Devices And Therapies Market, 2019-2027 (In $ Million)
Figure 22 India Antidepressants Drugs, Devices And Therapies Market, 2019-2027 (In $ Million)
Figure 23 China Antidepressants Drugs, Devices And Therapies Market, 2019-2027 (In $ Million)
Figure 24 Japan Antidepressants Drugs, Devices And Therapies Market, 2019-2027 (In $ Million)
Figure 25 South Korea Antidepressants Drugs, Devices And Therapies Market, 2019-2027 (In $ Million)
Figure 26 Australia Antidepressants Drugs, Devices And Therapies Market, 2019-2027 (In $ Million)
Figure 27 Rest Of Asia Pacific Antidepressants Drugs, Devices And Therapies Market, 2019-2027 (In $ Million)
Figure 28 Latin America Antidepressants Drugs, Devices And Therapies Market, 2019-2027 (In $ Million)
Figure 29 Middle East And Africa Antidepressants Drugs, Devices And Therapies Market, 2019-2027 (In $ Million)
Figure 30 Market Share Of Antidepressants Drug Manufacturers (Percentage Of Sales), 2018
Global Antioxidant Vitamins Market Research Report 2024
Published: 10-Jan-2024 Price: US 2900 Onwards Pages: 100
The global Antioxidant Vitamins market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030.
North American market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030.
Asia-Pacific market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ millio......
Global Clavulanate Potassium Market Research Report 2024
Published: 10-Jan-2024 Price: US 2900 Onwards Pages: 86
The global Clavulanate Potassium market was valued at US$ 446.6 million in 2023 and is anticipated to reach US$ 637.2 million by 2030, witnessing a CAGR of 5.2% during The forecast period 2024-2030.
North American market for Clavulanate Potassium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030.
Asia-Pacific market for Clavulanate Potassium is estimated to increase from $ million in 2023......
Global Amoxicillin Sodium Market Research Report 2024
Published: 10-Jan-2024 Price: US 2900 Onwards Pages: 84
The global Amoxicillin Sodium market was valued at US$ 460.9 million in 2023 and is anticipated to reach US$ 735.1 million by 2030, witnessing a CAGR of 7.0% during The forecast period 2024-2030.
North American market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030.
Asia-Pacific market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach......
Global Melatonin Supplements Market Research Report 2024
Published: 10-Jan-2024 Price: US 2900 Onwards Pages: 106
The global Melatonin Supplements market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030.
North American market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030.
Asia-Pacific market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ mil......
Global Sleeping Pills (Prescription Drugs) Market Research Report 2024
Published: 10-Jan-2024 Price: US 2900 Onwards Pages: 93
The global Sleeping Pills (Prescription Drugs) market was valued at US$ 1022.3 million in 2023 and is anticipated to reach US$ 1437.8 million by 2030, witnessing a CAGR of 4.9% during The forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical......
Global Sleeping Pills Market Research Report 2024
Published: 10-Jan-2024 Price: US 2900 Onwards Pages: 94
The global Sleeping Pills market was valued at US$ 2042.3 million in 2023 and is anticipated to reach US$ 2979.5 million by 2030, witnessing a CAGR of 3.8% during The forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......
Global Zinc Oral Drops Market Research Report 2024
Published: 10-Jan-2024 Price: US 2900 Onwards Pages: 85
The global Zinc Oral Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030.
North American market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030.
Asia-Pacific market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a......
Global Zinc Drops Market Research Report 2024
Published: 10-Jan-2024 Price: US 2900 Onwards Pages: 85
The global Zinc Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030.
North American market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030.
Asia-Pacific market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % duri......
Global Anti-Infectives Market Research Report 2024
Published: 10-Jan-2024 Price: US 2900 Onwards Pages: 78
The global Anti-Infectives market was valued at US$ 22700 million in 2023 and is anticipated to reach US$ 27480 million by 2030, witnessing a CAGR of 2.3% during The forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estima......
SERVICES
Value for Money
We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
Ever Growing Inventory
Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
One Stop Solution
Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
Dedicated Client Engagement
Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
Saving Time and Efforts
Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
Payment Flexibility
Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
Post-Purchase Research Support
Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements.
Subscription Offers & Packages (Get in touch with us for more details -
[email protected] / +1 888 391 5441 )
- Ad Hoc
-
- Pay - as - you - go / Bucket Subscriptions
- Fixed Cost for #of reports
- Customize / Personalize as per your needs
